Mechanisms of thrombin-induced modifications of human platelet cytoskeleton.
Thrombin treated with phenylmethanesulphonyl fluoride, like active enzyme, promotes modifications to human platelet cytoskeleton. The removal of active thrombin by hirudin partially reverses this process. Chymotrypsin-treated platelets do not modify their cytoskeleton after thrombin stimulus, but are still able to increase their adhesiveness to collagen. It is concluded that thrombin influences the cytoskeleton and adhesion by non-enzymic mechanisms which may be mediated by different modulators.
D001792:Blood Platelets / Q000187:drug effects*; D003094:Collagen / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000097:blood; D003599:Cytoskeleton / Q000187:drug effects; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D066298:In Vitro Techniques; D010973:Platelet Adhesiveness / Q000187:drug effects; D013917:Thrombin / Q000494:pharmacology*
D003598:Cytoskeletal Proteins; D003094:Collagen; D013917:Thrombin